Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Regis Healthcare Ltd
ASX:REG

Watchlist Manager
Regis Healthcare Ltd Logo
Regis Healthcare Ltd
ASX:REG
Watchlist
Price: 4.52 AUD -2.16% Market Closed
Market Cap: AU$1.4B
Write Note Create Alert Ask AI

Wall St Price Targets

REG Price Targets Summary
Regis Healthcare Ltd

Wall Street analysts forecast REG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REG is 6.09 AUD with a low forecast of 5.05 AUD and a high forecast of 7.77 AUD.

REG Lowest Forecast
Wall Street Target
AU$5.05
12% Upside
REG Average Forecast
Wall Street Target
AU$6.09
35% Upside
REG Highest Forecast
Wall Street Target
AU$7.77
72% Upside
Lowest Forecast
Price Target
5.05 AUD
12% Upside
Average Forecast
Price Target
6.09 AUD
35% Upside
Highest Forecast
Price Target
7.77 AUD
72% Upside
Regis Healthcare Ltd Competitors:
Price Targets

Revenue
Forecast

11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 7 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

2% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
2% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 7 years is 19%.

What are analyst estimates?

Pre-Tax Income
Forecast

10% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
10% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 12%.

What are analyst estimates?

Net Income
Forecast

10% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
10% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 7 years is 15%.

What are analyst estimates?

Continue REG Research

Summary
REG intrinsic value, competitors valuation, and company profile.
DCF Valuation
REG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
REG stock valuation using valuation multiples.
Wall St Estimates
REG price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
REG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is REG's stock price target?
Price Target
6.09 AUD

According to Wall Street analysts, the average 1-year price target for REG is 6.09 AUD with a low forecast of 5.05 AUD and a high forecast of 7.77 AUD.

What is the Revenue forecast for Regis Healthcare Ltd?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 7 years is 9%.

What is the Operating Income forecast for Regis Healthcare Ltd?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 7 years is 19%.

What is the Pre-Tax Income forecast for Regis Healthcare Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Regis Healthcare Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 7 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.